Questions discussed in this category
Would you have a different opinion based on whether it is a new therapy or an existing and previously well-tolerated therapy for the patient?
Any differences in the risks between SBRT vs. conventionally fractionation? Concurrent immunotherapy?
Should staging and treatment decisions be made based on imaging alone?
12670124901078869366816
Papers discussed in this category
Adv Radiat Oncol, 2020 May 05
Cancer Discov, 2020 May 01
Lancet, 2020 May 28
Int. J. Radiat. Oncol. Biol. Phys., 2020 Apr 14
BMJ Open, 2019 May 05
Rheumatol Int, 2021 Jan 29
Eur Respir Rev, 2021 Dec 15
Ann Am Thorac Soc,